Abstract:Precision medicine is a potential effective therapeutic for various human diseases. Currently, metal complex-based drugs are being successfully used in clinical applications owing to diverse properties such as multiple redox states, photo-induced ligand exchange, and preferential ligand and coordination numbers, which facilitate drug design and development. However, drawbacks such as toxicity, lack of specificity, and severe side effects have hampered their therapeutic outcome. Therefore, innovative strategies for improving the specificity and pharmacokinetics of conventional metal complex-based therapeutic agents are required. Recently, nanotechnology, which provides a unique toolbox for developing effective and safer medicine, has attracted considerable attention, mainly because of their ability to reduce side effects and enhance drug loading efficiency and pharmacokinetics. Considering the promising chemical and physical properties of diverse nanostructures, nanoformulation of metal complexes can be used to effectively address the problems associated with current metallodrug complexes, especially those based on stimuli-responsive therapeutic strategies, with excellent spatial, temporal, and dosage control. In this review, we have mainly focused on the specificity and environment-responsiveness of metallodrug nanoformulations as therapeutics, and summarized the recent strategies being used for developing metal complex-functionalized intelligent nanoplatforms, which respond to various types of stimuli, including endogenous signals (pH, redox conditions, and enzyme activities) or external triggers (light irradiation and magnetic field manipulations). In addition, we have also discussed the potential challenges associated with use of metallodrugs and their nanoformulations as effective precision therapy with improved specificity and minimal side effects.

In situ analysis of metallodrugs at the single-cell level based on synchrotron radiation technology

Visualization of metallodrugs in single cells by secondary ion mass spectrometry imaging

In situ label-free X-ray imaging for visualizing the localization of nanomedicines and subcellular architecture in intact single cells

Synchrotron-based X-ray Microscopic Studies for Bioeffects of Nanomaterials.

Synchrotron radiation: A key tool for drug discovery

Application of Synchrotron X-ray Imaging Technology in Cellular Imaging of Nanoprobes

Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development

Application of synchrotron radiation in biological imaging analysis

Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs.

Approaches Towards Understanding the Mechanism-of-action of Metallodrugs

Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs

Recent Advancements in Single-Cell Metabolic Analysis for Pharmacological Research

X-ray-Based Techniques to Study the Nano–Bio Interface

Iterative nanoparticle bioengineering enabled by x-ray fluorescence imaging

Application Of Metallomics And Metalloproteomics For Understanding The Molecular Mechanisms Of Action Of Metal-Based Drugs

Synchrotron‐Based X‐ray Microscopy for Nanoscale Bioimaging

Recent Advances in Luminescent Metallacycle/Metallacage for Biomedical Imaging and Cancer Therapy

Non-targeted metallomics through synchrotron radiation X-ray fluorescence with machine learning for cancer screening using blood samples

Nanoformulation of Metal Complexes: Intelligent Stimuli-Responsive Platforms for Precision Therapeutics

In Situ Surface-Enhanced Raman Scattering Spectroscopy Exploring Molecular Changes of Drug-Treated Cancer Cell Nucleus

Subcellular localization of drug distribution by super-resolution ion beam imaging